JP2016501026A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501026A5 JP2016501026A5 JP2015547532A JP2015547532A JP2016501026A5 JP 2016501026 A5 JP2016501026 A5 JP 2016501026A5 JP 2015547532 A JP2015547532 A JP 2015547532A JP 2015547532 A JP2015547532 A JP 2015547532A JP 2016501026 A5 JP2016501026 A5 JP 2016501026A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- culture medium
- cells
- sodium
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000001963 growth medium Substances 0.000 claims description 12
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims description 10
- 239000003381 stabilizer Substances 0.000 claims description 7
- 239000002518 antifoaming agent Substances 0.000 claims description 6
- 239000012679 serum free medium Substances 0.000 claims description 6
- 239000005700 Putrescine Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 23
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims 16
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 16
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims 15
- 235000019136 lipoic acid Nutrition 0.000 claims 15
- 229960002663 thioctic acid Drugs 0.000 claims 15
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 12
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims 12
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 12
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 12
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 12
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 12
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 12
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 12
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 12
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 claims 12
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims 12
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 10
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims 8
- 102000004877 Insulin Human genes 0.000 claims 8
- 108090001061 Insulin Proteins 0.000 claims 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical class [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical class [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 8
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 8
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims 8
- 102000004338 Transferrin Human genes 0.000 claims 8
- 108090000901 Transferrin Proteins 0.000 claims 8
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims 8
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims 8
- 229940031098 ethanolamine Drugs 0.000 claims 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 8
- 229940125396 insulin Drugs 0.000 claims 8
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 8
- 235000002639 sodium chloride Nutrition 0.000 claims 8
- 239000011781 sodium selenite Substances 0.000 claims 8
- 235000015921 sodium selenite Nutrition 0.000 claims 8
- 229960001471 sodium selenite Drugs 0.000 claims 8
- 239000012581 transferrin Substances 0.000 claims 8
- 229940088594 vitamin Drugs 0.000 claims 8
- 229930003231 vitamin Natural products 0.000 claims 8
- 235000013343 vitamin Nutrition 0.000 claims 8
- 239000011782 vitamin Substances 0.000 claims 8
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 claims 6
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims 6
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims 6
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims 6
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims 6
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 claims 6
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims 6
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims 6
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims 6
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims 6
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims 6
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 6
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 6
- 229930064664 L-arginine Natural products 0.000 claims 6
- 235000014852 L-arginine Nutrition 0.000 claims 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 6
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 6
- 235000019393 L-cystine Nutrition 0.000 claims 6
- 239000004158 L-cystine Substances 0.000 claims 6
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 6
- 229930182844 L-isoleucine Natural products 0.000 claims 6
- 239000004395 L-leucine Substances 0.000 claims 6
- 235000019454 L-leucine Nutrition 0.000 claims 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 6
- 229930195722 L-methionine Natural products 0.000 claims 6
- 229930182821 L-proline Natural products 0.000 claims 6
- 239000004473 Threonine Substances 0.000 claims 6
- 229960005305 adenosine Drugs 0.000 claims 6
- 229960003767 alanine Drugs 0.000 claims 6
- 229940024606 amino acid Drugs 0.000 claims 6
- 235000001014 amino acid Nutrition 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 6
- 229960001230 asparagine Drugs 0.000 claims 6
- 229960005261 aspartic acid Drugs 0.000 claims 6
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 claims 6
- 229960003067 cystine Drugs 0.000 claims 6
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims 6
- 229960002989 glutamic acid Drugs 0.000 claims 6
- 229940029575 guanosine Drugs 0.000 claims 6
- 229960002885 histidine Drugs 0.000 claims 6
- 229960000310 isoleucine Drugs 0.000 claims 6
- 229960003136 leucine Drugs 0.000 claims 6
- 229960004452 methionine Drugs 0.000 claims 6
- 229960002429 proline Drugs 0.000 claims 6
- 229960001153 serine Drugs 0.000 claims 6
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims 6
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 6
- 229960002898 threonine Drugs 0.000 claims 6
- 229960004441 tyrosine Drugs 0.000 claims 6
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 claims 6
- 229940045145 uridine Drugs 0.000 claims 6
- 229960004295 valine Drugs 0.000 claims 6
- 239000002777 nucleoside Substances 0.000 claims 5
- 125000003835 nucleoside group Chemical group 0.000 claims 5
- 239000000758 substrate Substances 0.000 claims 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 4
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims 4
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 claims 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical class [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 4
- 235000019743 Choline chloride Nutrition 0.000 claims 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims 4
- 239000004471 Glycine Substances 0.000 claims 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 4
- 229930182816 L-glutamine Natural products 0.000 claims 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims 4
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 claims 4
- FAPWYRCQGJNNSJ-CTWWJBIBSA-L calcium;3-[[(2s)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate Chemical compound [Ca+2].OCC(C)(C)[C@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-CTWWJBIBSA-L 0.000 claims 4
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims 4
- 229960003178 choline chloride Drugs 0.000 claims 4
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims 4
- 229960002104 cyanocobalamin Drugs 0.000 claims 4
- 235000000639 cyanocobalamin Nutrition 0.000 claims 4
- 239000011666 cyanocobalamin Substances 0.000 claims 4
- 229940068840 d-biotin Drugs 0.000 claims 4
- 229940052354 dibasic sodium phosphate heptahydrate Drugs 0.000 claims 4
- PYLIXCKOHOHGKQ-UHFFFAOYSA-L disodium;hydrogen phosphate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O PYLIXCKOHOHGKQ-UHFFFAOYSA-L 0.000 claims 4
- 229960000304 folic acid Drugs 0.000 claims 4
- 235000019152 folic acid Nutrition 0.000 claims 4
- 239000011724 folic acid Substances 0.000 claims 4
- 229960002449 glycine Drugs 0.000 claims 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims 4
- 229960003966 nicotinamide Drugs 0.000 claims 4
- 235000005152 nicotinamide Nutrition 0.000 claims 4
- 239000011570 nicotinamide Substances 0.000 claims 4
- 239000001103 potassium chloride Chemical class 0.000 claims 4
- 235000011164 potassium chloride Nutrition 0.000 claims 4
- 229960003581 pyridoxal Drugs 0.000 claims 4
- 235000008164 pyridoxal Nutrition 0.000 claims 4
- 239000011674 pyridoxal Substances 0.000 claims 4
- 235000008160 pyridoxine Nutrition 0.000 claims 4
- 239000011677 pyridoxine Substances 0.000 claims 4
- 229960002477 riboflavin Drugs 0.000 claims 4
- 235000019192 riboflavin Nutrition 0.000 claims 4
- 239000002151 riboflavin Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 229960003495 thiamine Drugs 0.000 claims 4
- 235000019157 thiamine Nutrition 0.000 claims 4
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims 4
- 239000011721 thiamine Substances 0.000 claims 4
- 229940104230 thymidine Drugs 0.000 claims 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical class [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 4
- 210000003954 umbilical cord Anatomy 0.000 claims 4
- 229940011671 vitamin b6 Drugs 0.000 claims 4
- 238000012258 culturing Methods 0.000 claims 3
- 239000004017 serum-free culture medium Substances 0.000 claims 3
- -1 Salts sodium monophosphate Chemical class 0.000 claims 2
- 239000001110 calcium chloride Substances 0.000 claims 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims 2
- 235000011148 calcium chloride Nutrition 0.000 claims 2
- 230000001419 dependent effect Effects 0.000 claims 2
- 229960002743 glutamine Drugs 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 239000011780 sodium chloride Chemical class 0.000 claims 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims 2
- 102100022749 Aminopeptidase N Human genes 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 102000006354 HLA-DR Antigens Human genes 0.000 claims 1
- 108010058597 HLA-DR Antigens Proteins 0.000 claims 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 1
- 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 claims 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 1
- 101001008874 Homo sapiens Mast/stem cell growth factor receptor Kit Proteins 0.000 claims 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims 1
- 102000004895 Lipoproteins Human genes 0.000 claims 1
- 108090001030 Lipoproteins Proteins 0.000 claims 1
- 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 claims 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 235000010755 mineral Nutrition 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 238000010899 nucleation Methods 0.000 claims 1
- 230000007651 self-proliferation Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 229940054269 sodium pyruvate Drugs 0.000 claims 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 claims 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 229940098773 bovine serum albumin Drugs 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229920001993 poloxamer 188 Polymers 0.000 description 2
- 239000002609 medium Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/715,532 | 2012-12-14 | ||
| US13/715,532 US20140170748A1 (en) | 2012-12-14 | 2012-12-14 | Nutrient Enriched Media for hUTC Growth |
| PCT/US2013/074615 WO2014093598A1 (en) | 2012-12-14 | 2013-12-12 | NUTRIENT ENRICHED MEDIA FOR hUTC GROWTH |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018165126A Division JP6595061B2 (ja) | 2012-12-14 | 2018-09-04 | 単離された臍帯組織由来細胞を培養する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016501026A JP2016501026A (ja) | 2016-01-18 |
| JP2016501026A5 true JP2016501026A5 (enExample) | 2017-02-16 |
| JP6404227B2 JP6404227B2 (ja) | 2018-10-10 |
Family
ID=49881127
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015547532A Expired - Fee Related JP6404227B2 (ja) | 2012-12-14 | 2013-12-12 | ｈＵＴＣ増殖用栄養強化培地 |
| JP2018165126A Expired - Fee Related JP6595061B2 (ja) | 2012-12-14 | 2018-09-04 | 単離された臍帯組織由来細胞を培養する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018165126A Expired - Fee Related JP6595061B2 (ja) | 2012-12-14 | 2018-09-04 | 単離された臍帯組織由来細胞を培養する方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20140170748A1 (enExample) |
| EP (2) | EP2931875B1 (enExample) |
| JP (2) | JP6404227B2 (enExample) |
| KR (2) | KR102151588B1 (enExample) |
| CN (2) | CN105026551B (enExample) |
| AR (2) | AR093985A1 (enExample) |
| AU (2) | AU2013359265B2 (enExample) |
| BR (1) | BR112015013685A8 (enExample) |
| CA (1) | CA2895079C (enExample) |
| ES (1) | ES2667573T3 (enExample) |
| MX (2) | MX364731B (enExample) |
| PH (1) | PH12015501310B1 (enExample) |
| PL (1) | PL2931875T3 (enExample) |
| RU (2) | RU2684306C2 (enExample) |
| SG (2) | SG11201504547SA (enExample) |
| TW (1) | TWI620818B (enExample) |
| WO (1) | WO2014093598A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10791730B2 (en) * | 2016-01-14 | 2020-10-06 | DePuy Synthes Products, Inc. | Composition and methods for cryopreservation of hUTC |
| US10894947B1 (en) * | 2016-04-29 | 2021-01-19 | Hope Biosciences, Llc | Method for generating protein rich conditioned medium |
| US11111480B2 (en) | 2016-04-29 | 2021-09-07 | Hope Biosctences, Llc | Culture media for multipotent stem cells |
| CN106434532A (zh) * | 2016-12-22 | 2017-02-22 | 叶宗耀 | 一种培养肝细胞的培养基及其制备方法 |
| CN106957815B (zh) * | 2017-03-16 | 2021-05-07 | 杨涛 | 一种用于人类多潜能干细胞的无血清培养基的配方 |
| JP7181534B2 (ja) * | 2017-03-28 | 2022-12-01 | 味の素株式会社 | 未分化維持培地添加剤 |
| CN107119017B (zh) * | 2017-05-25 | 2020-05-26 | 山东省医药生物技术研究中心 | 一种骨肉瘤细胞的无血清培养基及其制备方法 |
| KR20210068488A (ko) * | 2018-09-28 | 2021-06-09 | 아지노모토 가부시키가이샤 | 동물 세포의 배양용 첨가물, 배양용 배지 및 배양 방법 |
| EP3947642A4 (en) * | 2019-04-05 | 2022-12-14 | The University of Hong Kong | CULTURE MEDIUM FOR MAMMALIAN PLURIPOTENTE STEM CELLS, COMPOSITION AND METHODS |
| WO2020219812A1 (en) | 2019-04-26 | 2020-10-29 | Allogene Therapeutics, Inc. | Methods of manufacturing allogeneic car t cells |
| EP3983481A1 (en) * | 2019-06-13 | 2022-04-20 | Corning Incorporated | Dissolvable microcarriers for culturing cells and related methods |
| CN114058573B (zh) * | 2020-08-03 | 2024-04-05 | 上海原天生物科技有限公司 | 一种含有生物素的培养基 |
| CN112608892B (zh) * | 2020-12-25 | 2023-11-14 | 深圳博雅感知药业有限公司 | 血小板裂解物用于无血清分离和传代培养脐带间充质干细胞的方法 |
| KR20220104321A (ko) | 2021-01-18 | 2022-07-26 | 주식회사 엑소코바이오 | 엑소좀 및/또는 세포외 소포체의 생성 촉진 내지는 생산성 향상 방법 |
| US11735303B2 (en) | 2021-06-22 | 2023-08-22 | David Haase | Apparatus and method for determining a composition of a replacement therapy treatment |
| WO2024253069A1 (ja) * | 2023-06-06 | 2024-12-12 | 東ソー株式会社 | 温度応答性マイクロキャリア |
| KR20250140345A (ko) * | 2024-03-18 | 2025-09-25 | 주식회사 심플플래닛 | 세포 증식 활성이 우수한 식용 배지 조성물 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA776251B (en) * | 1976-11-11 | 1978-07-26 | Massachusetts Inst Technology | Improved cell culture microcarriers |
| WO1991010726A1 (en) * | 1990-01-22 | 1991-07-25 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Co-independent growth medium for maintenance and propagation of cells |
| JP2993614B2 (ja) * | 1990-11-20 | 1999-12-20 | 有限会社野々川商事 | 新規化粧料、グルコサミノグリカン生成促進剤および美白剤 |
| US7556958B1 (en) | 1997-04-08 | 2009-07-07 | The Rockefeller University | Enzyme derived from thermophilic organisms that functions as a chromosomal replicase, and preparation and uses thereof |
| CA2438148A1 (en) * | 2001-02-15 | 2002-08-29 | Centocor, Inc. | Chemically defined medium for cultured mammalian cells |
| US9969980B2 (en) | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| WO2003057865A1 (es) * | 2002-01-09 | 2003-07-17 | Derbiotek, S.L. | Composicion y procedimiento para crear, regenerar y reparar tejidos mediante implante biologico portador de celulas y enriquecido con concentrado de plaquetas mas suplementos. |
| US8518390B2 (en) * | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
| CA2530421C (en) | 2003-06-27 | 2015-04-21 | Ethicon, Incorporated | Repair and regeneration of ocular tissue using postpartum-derived cells |
| US20050005863A1 (en) | 2003-07-10 | 2005-01-13 | Snider Tracy Aurora Christine | Distillers solubles as the primary constituent in protein blocks for livestock |
| EP1682075A4 (en) * | 2003-11-07 | 2009-12-09 | Univ Florida | BREEDING AND DIFFERENTIATION OF NEURAL CREATOR CELLS |
| JP2008518597A (ja) * | 2004-10-29 | 2008-06-05 | セントカー・インコーポレーテツド | 化学的規定培地組成物 |
| JP5340599B2 (ja) * | 2004-12-23 | 2013-11-13 | エシコン・インコーポレイテッド | 臍帯組織由来産褥細胞ならびにその製造方法および使用方法 |
| JP5179376B2 (ja) | 2005-12-19 | 2013-04-10 | エシコン・インコーポレイテッド | ローラーボトルでの分娩後取り出し細胞の体外増殖 |
| AU2007270069B2 (en) * | 2006-07-06 | 2013-05-16 | Es Cell International Pte Ltd | Method for stem cell culture and cells derived therefrom |
| ES2524443T3 (es) * | 2006-11-13 | 2014-12-09 | DePuy Synthes Products, LLC | Expansión in vitro de células postparto usando microportadores |
| US20100143289A1 (en) * | 2006-12-19 | 2010-06-10 | Michael Cohen | Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof |
| EP2028268A1 (en) * | 2007-08-20 | 2009-02-25 | Université Libre De Bruxelles | Generation of neuronal cells from pluripotent stem cells |
| CN100482783C (zh) * | 2007-11-27 | 2009-04-29 | 天津百若克医药生物技术有限责任公司 | 一种用于Vero细胞的培养基及其培养方法 |
| US10179900B2 (en) * | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
| JP2013500717A (ja) * | 2009-07-28 | 2013-01-10 | コーニング インコーポレイテッド | 細胞を培養するための合成マイクロキャリア |
-
2012
- 2012-12-14 US US13/715,532 patent/US20140170748A1/en not_active Abandoned
-
2013
- 2013-12-12 MX MX2015007594A patent/MX364731B/es active IP Right Grant
- 2013-12-12 AU AU2013359265A patent/AU2013359265B2/en not_active Ceased
- 2013-12-12 RU RU2018112452A patent/RU2684306C2/ru active
- 2013-12-12 JP JP2015547532A patent/JP6404227B2/ja not_active Expired - Fee Related
- 2013-12-12 ES ES13812432.6T patent/ES2667573T3/es active Active
- 2013-12-12 KR KR1020197003828A patent/KR102151588B1/ko not_active Expired - Fee Related
- 2013-12-12 CN CN201380072759.4A patent/CN105026551B/zh not_active Expired - Fee Related
- 2013-12-12 WO PCT/US2013/074615 patent/WO2014093598A1/en not_active Ceased
- 2013-12-12 KR KR1020157018827A patent/KR101948237B1/ko not_active Expired - Fee Related
- 2013-12-12 CA CA2895079A patent/CA2895079C/en active Active
- 2013-12-12 SG SG11201504547SA patent/SG11201504547SA/en unknown
- 2013-12-12 BR BR112015013685A patent/BR112015013685A8/pt active Search and Examination
- 2013-12-12 RU RU2015128276A patent/RU2653449C2/ru active
- 2013-12-12 CN CN202010511518.7A patent/CN111690602A/zh active Pending
- 2013-12-12 EP EP13812432.6A patent/EP2931875B1/en not_active Not-in-force
- 2013-12-12 SG SG10201801924VA patent/SG10201801924VA/en unknown
- 2013-12-12 PL PL13812432T patent/PL2931875T3/pl unknown
- 2013-12-12 EP EP18159408.6A patent/EP3382007A1/en not_active Withdrawn
- 2013-12-13 AR ARP130104702A patent/AR093985A1/es unknown
- 2013-12-13 TW TW102146011A patent/TWI620818B/zh not_active IP Right Cessation
-
2015
- 2015-06-09 PH PH12015501310A patent/PH12015501310B1/en unknown
- 2015-06-12 MX MX2018013469A patent/MX2018013469A/es unknown
-
2018
- 2018-09-04 JP JP2018165126A patent/JP6595061B2/ja not_active Expired - Fee Related
-
2019
- 2019-03-29 AU AU2019202191A patent/AU2019202191B2/en not_active Ceased
-
2020
- 2020-02-10 AR ARP200100348A patent/AR118040A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016501026A5 (enExample) | ||
| RU2015128276A (ru) | Обогащенная питательная среда для выращивания клеток, извлеченных из ткани пуповины человека | |
| CN103857789B (zh) | 制备间充质干细胞基础培养基和利用间充质干细胞基础培养基制备细胞治疗产品的方法及用该培养基得到的分化产品 | |
| NZ591651A (en) | High titer antibody production and culture media comprising glucose, soy or wheat hydrolsyate, amino acids, and other chemical compounds | |
| JP5420837B2 (ja) | 胚幹細胞の培地及び培養 | |
| US7442548B2 (en) | Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid | |
| CN102228016A (zh) | 一种神经干细胞冻存复苏的方法 | |
| CN101679944A (zh) | 用于发育细胞的含有高浓度硫辛酸的培养基 | |
| CN101182490A (zh) | 一种用于Vero细胞的培养基及其培养方法 | |
| US7923245B2 (en) | Medium for ES culturing | |
| US20170342378A1 (en) | Stem cell bank | |
| JP6845218B2 (ja) | 細胞におけるグルタチオンレベルを増加させる方法 | |
| KR20220046643A (ko) | 세포를 배양하기 위한 세포 배양 배지, 세포를 배양하기 위한 방법, 그리고 세포 배양액중 재조합 단백질 적어도 1개를 발현시키기 위한 방법 | |
| CN1894400B (zh) | 无血清vero细胞建库方法 | |
| IL292933A (en) | Serum-free human pluripotent stem cell culture medium | |
| JP7719520B2 (ja) | ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法 | |
| JPWO2020067502A1 (ja) | 動物細胞の培養用添加物、培養用培地および培養方法 | |
| CZ36273U1 (cs) | Kultivační médium pro eliminaci defektů zrání savčích oocytů vyvolaných butylfenylmethylpropionalem -1 | |
| US20220002676A1 (en) | Methods of Preserving Cells for Space Exploration and Compositions Related Thereto | |
| CZ35511U1 (cs) | Kultivační médium pro eliminaci defektů zrání savčích oocytů vyvolaných bisfenolem A nebo bisfenolem S - 1 | |
| CZ35512U1 (cs) | Kultivační médium pro eliminaci defektů zrání savčích oocytů vyvolaných bisfenolem A nebo bisfenolem S - 2 | |
| US20140256044A1 (en) | Culture media | |
| Mizuguchi | 1 Nissui Pharmaceutical Co. Ltd., Yuuki, Ibaraki, Japan 2 Department of Agricultural Chemistry, The University of Tokyo, Japan |